Arrowhead Pharmaceuticals Inc.

In News

Arrowhead Pharmaceuticals Announces ARO-MAPT Interim Phase 1/2a Clinical Data Demonstrating Deep and Durable Tau Reductions in Healthy Volunteers - Arrowhead Pharmaceuticals, Inc.

Arrowhead Pharmaceuticals, Inc. - Oct 14, 2026

Arrowhead Pharmaceuticals (ARWR) Reports Fresh ARO MAPT Data, Is The Stock Still Cheap? - Yahoo Finance

Yahoo Finance - Oct 16, 2026

Arrowhead Pharmaceuticals, Inc. (ARWR) Discusses ARO-MAPT Interim Results and TRiM CNS Delivery Platform in Investigational CNS Pipeline - Slideshow (NASDAQ:ARWR) 2026-10-14 - Seeking Alpha

Seeking Alpha - Oct 14, 2026

Arrowhead Pharmaceuticals (NasdaqGS:ARWR) Stock Forecast & Analyst Predictions - Simply Wall Street

Simply Wall Street - Oct 15, 2026

Arrowhead’s blood-brain barrier tech is ‘arguably better’ than others, analysts say after data drop - BioSpace

BioSpace - Oct 15, 2026

Arrowhead Pharmaceuticals Advances Alzheimer's Drug Push With Promising Early Clinical Results - Benzinga

Benzinga - Oct 14, 2026

Arrowhead Pharmaceuticals to Host a Webinar with Interim Clinical Data from a Phase 1/2a Study of ARO-MAPT for the Treatment of Alzheimer’s Disease and Other Tauopathies - Arrowhead Pharmaceuticals, Inc.

Arrowhead Pharmaceuticals, Inc. - Sep 29, 2026

Arrowhead Pharmaceuticals Reports Up to 73% CSF Tau Reduction in Early ARO-MAPT Study - Yahoo Finance

Yahoo Finance - Oct 14, 2026

Arrowhead Pharmaceuticals: ARO-MAPT Results Unlock A New Platform (NASDAQ:ARWR) - Seeking Alpha

Seeking Alpha - Oct 15, 2026

Arrowhead Pharmaceuticals Presents Phase 3 SHASTA-3 and SHASTA-4 Data Demonstrating Plozasiran Reduced Acute Pancreatitis Events in Patients with Severe Hypertriglyceridemia - Arrowhead Pharmaceuticals, Inc.

Arrowhead Pharmaceuticals, Inc. - Aug 30, 2026

Arrowhead Pharmaceuticals Advances Alzheimer's Drug Push With Promising Early Clinical Results - Yahoo

Yahoo - Oct 16, 2026

Arrowhead Pharmaceuticals Reports Fiscal 2026 Third Quarter Results - Arrowhead Pharmaceuticals, Inc.

Arrowhead Pharmaceuticals, Inc. - Aug 04, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment